Skip to content

Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images

Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04972695
Enrollment
615
Registered
2021-07-22
Start date
2021-05-07
Completion date
2022-02-23
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Glaucoma, Suspect, Ocular Hypertension

Keywords

Deep Learning, Diagnoses Disease, Glaucoma, retinographies

Brief summary

Clinical, cross-sectional and prospective study to assess the images of the posterior pole of the retina of patients from the Glaucoma Unit of the IOBA and the Hospital Clínico Universitario de Valladolid during the period between May and December 2021. The aim of the project is to provide a sufficient number of images from posterior pole retinographies in patients with suspected glaucoma or with diagnosis of glaucoma in order to determine the sensitivity and specificity of an automatic glaucoma screening algorithm developed by the company Transmural Biotech S.L.

Interventions

DIAGNOSTIC_TESTFundus Photographs (retinographies)

Fundus photographs under mydriasis

Sponsors

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Primary open angle glaucoma or ocular hypertension * Signed informed consent * Visual field examination within the last 12 months

Exclusion criteria

* Ocular or systemic pathologies that may interfere with the quality of the retinographic image or the results of the visual field * Congenital anomalies of the papilla that seriously alter its structure * High ametropia (\> 10 diopters) * Pharmacological Mydriasis contraindication.

Design outcomes

Primary

MeasureTime frame
Sensitivity and Specificity of an automated classification system for retinographiesDay 0

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026